Smith RB - Search Results

1

The effect of colestipol dose on postprandial serum bile acid concentration: assessment by an enzymic bioluminescence procedure.

Fleishaker JC, Rossi SS, Smith RB, Welshman IR, Daei F, Angellotti MA, Hofmann AF. Fleishaker JC, et al. Among authors: smith rb. Aliment Pharmacol Ther. 1990 Dec;4(6):623-33. doi: 10.1111/j.1365-2036.1990.tb00510.x. Aliment Pharmacol Ther. 1990. PMID: 2129649 Clinical Trial.

2

Effect of the bile-acid sequestrant colestipol on postprandial serum bile-acid concentration: evaluation by bioluminescent enzymic analysis.

Rossi SS, Wayne ML, Smith RB, Wright CE, Andreadis NA, Hofmann AF. Rossi SS, et al. Among authors: smith rb. Aliment Pharmacol Ther. 1989 Feb;3(1):41-6. doi: 10.1111/j.1365-2036.1989.tb00189.x. Aliment Pharmacol Ther. 1989. PMID: 2491457

3

Comparison of adinazolam pharmacokinetics and effects in healthy and cirrhotic subjects.

Kroboth PD, Maxwell RA, Fleishaker JC, Van Thiel DH, Smith RB. Kroboth PD, et al. Among authors: smith rb. J Clin Pharmacol. 1991 Jun;31(6):580-6. doi: 10.1002/j.1552-4604.1991.tb03741.x. J Clin Pharmacol. 1991. PMID: 1880225

4

Multiple-dose pharmacokinetics and pharmacodynamics of adinazolam in elderly subjects.

Fleishaker JC, Phillips JP, Smith TC, Smith RB. Fleishaker JC, et al. Among authors: smith rb, smith tc. Pharm Res. 1989 May;6(5):379-86. doi: 10.1023/a:1015975214070. Pharm Res. 1989. PMID: 2748528 Clinical Trial.

5

Pharmacokinetics and pharmacodynamics of alprazolam following single and multiple oral doses of a sustained-release formulation.

Fleishaker JC, Phillips JP, Eller MG, Smith RB. Fleishaker JC, et al. Among authors: smith rb. J Clin Pharmacol. 1989 Jun;29(6):543-9. doi: 10.1002/j.1552-4604.1989.tb03379.x. J Clin Pharmacol. 1989. PMID: 2754023

6

Compartmental model analysis in pharmacokinetics.

Fleishaker JC, Smith RB. Fleishaker JC, et al. Among authors: smith rb. J Clin Pharmacol. 1987 Dec;27(12):922-6. doi: 10.1002/j.1552-4604.1987.tb05591.x. J Clin Pharmacol. 1987. PMID: 3325530 Review. No abstract available.

7

An evaluation of population pharmacokinetics in therapeutic trials. Part II. Detection of a drug-drug interaction.

Grasela TH Jr, Antal EJ, Ereshefsky L, Wells BG, Evans RL, Smith RB. Grasela TH Jr, et al. Among authors: smith rb. Clin Pharmacol Ther. 1987 Oct;42(4):433-41. doi: 10.1038/clpt.1987.174. Clin Pharmacol Ther. 1987. PMID: 3665341

8

Pharmacodynamics of triazolam after intravenous administration.

Smith RB, Kroboth PD, Varner PD. Smith RB, et al. J Clin Pharmacol. 1987 Dec;27(12):971-9. doi: 10.1002/j.1552-4604.1987.tb05599.x. J Clin Pharmacol. 1987. PMID: 3437069

9

An evaluation of population pharmacokinetics in therapeutic trials. Part III. Prospective data collection versus retrospective data assembly.

Antal EJ, Grasela TH Jr, Smith RB. Antal EJ, et al. Among authors: smith rb. Clin Pharmacol Ther. 1989 Nov;46(5):552-9. doi: 10.1038/clpt.1989.185. Clin Pharmacol Ther. 1989. PMID: 2684474 Clinical Trial.

10

Acute tolerance to triazolam during continuous and step infusions: estimation of the effect offset rate constant.

Kroboth PD, Bertz RJ, Smith RB. Kroboth PD, et al. Among authors: smith rb. J Pharmacol Exp Ther. 1993 Mar;264(3):1047-55. J Pharmacol Exp Ther. 1993. PMID: 8450449 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

827 results

Search Page

Filters